The biotech market looks poised for a robust expansion in the long term, owing to the rising need for personalized drugs, a strong drug pipeline, the use of advanced technologies like AI to aid drug development, and growing healthcare needs.
Amid this backdrop, investors could consider buying fundamentally strong biotech stocks such as Amgen Inc. (AMGN), Jazz Pharmaceuticals plc (JAZZ), and ANI Pharmaceuticals, Inc. (ANIP). Before exploring the fundamentals of these stocks, let’s first understand what’s shaping the biotech industry’s prospects.
